Fluorescein angiographic characteristic in predominantly classic and occult types of neovascular age-related macular degeneration treated with ranibizumab

BACKGROUND AND PURPOSE: Randomised-controlled clinical trials (the ANCHOR and MARINA) examined the intravitreal anti-vascular endothelial growth factor (anti-VEGF) efficacy for eyes having fluorescein angiographic classic and occult (OCC) neovascular lesions. No significant difference in the treatme...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Adv Ophthalmol
Главные авторы: Çavdarlı, Cemal, Çomçalı, Sebile, Topcu Yılmaz, Pınar, Alp, Mehmet Numan
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2021
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8053751/
https://ncbi.nlm.nih.gov/pubmed/33948533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/25158414211005305
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы